Husken_1995_Eur.J.Pharmacol_287_313

Reference

Title : Relaxant effect of levcromakalim in isolated human small subcutaneous arteries - Husken_1995_Eur.J.Pharmacol_287_313
Author(s) : Husken BC , Vroom MB , Timmenga EJ , Pfaffendorf M , van Zwieten PA
Ref : European Journal of Pharmacology , 287 :313 , 1995
Abstract :

The effect of levcromakalim, an ATP-sensitive K+ channel opener, on isolated subcutaneous arteries from mammary tissues obtained from female patients undergoing reconstructive breast surgery was investigated. The small arteries were preserved in the University of Wisconsin (UW) solution. The contractile responses to K+ and 9,11-dideoxy-11a,9a-epoxy-methano-prostaglandin F2 alpha (U46619) and the relexant responses to levcromakalim and to the endothelium-dependent vasodilator, methacholine, in these arteries remained fully intact after preservation in UW solution for at least 5 days. The pD2 value and maximal relaxation obtained from the concentration-response curve of levcromakalim (n = 7) were 5.78 +/- 0.23 and 81 +/- 6%, respectively. The vasodilator effect of levcromakalim was significantly antagonised by the ATP-sensitive K+ channel blocker, glibenclamide (1 and 3 microM). In conclusion, isolated human arteries contain ATP-sensitive K+ channels, which can be modulated by K+ channel openers and blockers. Subcutaneous small arteries, as used in our experiments, appear to be very suitable for pharmacological experiments.

PubMedSearch : Husken_1995_Eur.J.Pharmacol_287_313
PubMedID: 8991807

Related information

Citations formats

Husken BC, Vroom MB, Timmenga EJ, Pfaffendorf M, van Zwieten PA (1995)
Relaxant effect of levcromakalim in isolated human small subcutaneous arteries
European Journal of Pharmacology 287 :313

Husken BC, Vroom MB, Timmenga EJ, Pfaffendorf M, van Zwieten PA (1995)
European Journal of Pharmacology 287 :313